Getinge AB (publ) (OTCMKTS:GNGBY) Shares Pass Above 50 Day Moving Average – Time to Sell?

Getinge AB (publ) (OTCMKTS:GNGBYGet Free Report) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $20.30 and traded as high as $22.15. Getinge AB (publ) shares last traded at $22.08, with a volume of 5,574 shares trading hands.

Getinge AB (publ) Trading Up 0.6 %

The firm has a market capitalization of $6.01 billion, a P/E ratio of 38.73 and a beta of 0.81. The company has a quick ratio of 0.50, a current ratio of 0.78 and a debt-to-equity ratio of 0.06. The firm has a 50 day moving average of $20.30 and a 200-day moving average of $18.74.

Getinge AB (publ) (OTCMKTS:GNGBYGet Free Report) last released its earnings results on Tuesday, January 28th. The company reported $0.49 earnings per share for the quarter. Getinge AB (publ) had a return on equity of 9.84% and a net margin of 4.71%.

Getinge AB (publ) Increases Dividend

The company also recently announced a dividend, which will be paid on Wednesday, May 14th. Shareholders of record on Thursday, April 24th will be issued a $0.4326 dividend. This is a positive change from Getinge AB (publ)’s previous dividend of $0.42. The ex-dividend date is Thursday, April 24th. Getinge AB (publ)’s dividend payout ratio (DPR) is currently 43.86%.

Getinge AB (publ) Company Profile

(Get Free Report)

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.

Featured Articles

Receive News & Ratings for Getinge AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.